Gen-Wealth Partners’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Gen-Wealth Partners's UTHR Position: Q3 2026 in Review
Gen-Wealth Partners opened a new position in United Therapeutics (UTHR) in Q3 2026: 63 shares worth $34.4K. The stake represents 0.01% of the portfolio and ranks #461 among its holdings. This is a return to the name: Gen-Wealth Partners previously reported a position in UTHR as recently as Q4 2024.
Gen-Wealth Partners first reported a position in UTHR in Q3 2024 and has held it in 3 quarters since. The position peaked at $79.5K in Q3 2024. 848 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- Gen-Wealth Partners held 63 shares of United Therapeutics worth $34.4K as of Q3 2026.
- United Therapeutics was a new Gen-Wealth Partners position in Q3 2026.
- United Therapeutics made up 0.01% of Gen-Wealth Partners's portfolio in Q3 2026, its #461 holding.
- Gen-Wealth Partners first reported a position in United Therapeutics in Q3 2024 and has held it in 3 quarters since.
- Gen-Wealth Partners's United Therapeutics position peaked at $79.5K in Q3 2024.
- 848 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on Gen-Wealth Partners's 13F filing for Q3 2026, filed 4 Nov 2026.